Detalhe da pesquisa
1.
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
N Engl J Med
; 369(8): 722-31, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23964934
2.
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.
Eur Urol
; 65(2): 278-86, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706567
3.
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.
J Clin Oncol
; 32(14): 1412-8, 2014 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687826
4.
Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.
J Clin Oncol
; 32(18): 1868-70, 2014 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821880